文献速递神经肿瘤

伴有EWSR1-PLAGL1重排的中枢神经系统胚胎性肿瘤在复发时被重新分类为INI-1缺陷性肿瘤

Central nervous system embryonal tumors with EWSR1-PLAGL1 rearrangements reclassified as INI-1 deficient tumors at relapse.
PubMed 文献 · J Neurooncol · 2024-04-19

该文描述两例伴有EWSR1-PLAGL1重排的中枢神经系统胚胎性肿瘤患儿,诊断时依据组织学表现和分子数据分类,复发时均因INI-1缺失、SMARCB1改变及甲基化谱结果被重新分类为非典型畸胎样横纹肌样瘤(ATRT)。作者认为诊断时应考虑针对该疾病成分的治疗。

要点

  • 两例患儿诊断时为伴EWSR1-PLAGL1重排的中枢神经系统胚胎性肿瘤。
  • 复发时均因INI-1缺失、SMARCB1改变及甲基化谱结果重新分类为ATRT。
  • 作者认为诊断时应考虑针对该疾病成分的治疗。

核心结论

  • 伴有EWSR1-PLAGL1重排的中枢神经系统胚胎性肿瘤获得或包含SMARCB1改变的细胞群体,该成分在复发时占主导,作者认为诊断时应考虑针对该疾病成分的治疗。

研究设计与样本

  • 该文描述了在阿肯色儿童医院治疗的两例伴有EWSR1-PLAGL1重排的中枢神经系统胚胎性肿瘤患儿,并报告其组织病理学与分子数据。

主要发现

  • 两例患儿诊断时基于组织学表现和分子数据被分类为伴有EWSR1-PLAGL1重排的中枢神经系统胚胎性肿瘤。
  • 两例患儿复发时均基于INI-1缺失、SMARCB1改变及甲基化谱结果被重新分类为非典型畸胎样横纹肌样瘤(ATRT)。

临床怎么用

  • 作者认为诊断时应考虑针对SMARCB1改变细胞成分的治疗。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Central nervous system (CNS) embryonal tumors are a diverse group of malignant tumors typically affecting pediatric patients that recently have been better defined, and this paper describes evolution of a unique type of embryonal tumor at relapse. METHODS: Two pediatric patients with CNS embryonal tumors with EWSR1-PLAGL1 rearrangements treated at Arkansas Children's Hospital with histopathologic and molecular data are described. RESULTS: These two patients at diagnosis were classified as CNS embryonal tumors with EWSR1-PLAGL1 rearrangements based on histologic appearance and molecular data. At relapse both patient's disease was reclassified as atypical teratoid rhabdoid tumor (ATRT) based on loss of INI-1, presence of SMARCB1 alterations, and methylation profiling results. CONCLUSION: CNS embryonal tumors with EWSR1-PLAGL1 rearrangements acquire or include a population of cells with SMARCB1 alterations that are the component that predominate at relapse, suggesting treatment aimed at this disease component at diagnosis should be considered.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Bielamowicz KJ, Littrell MB, Albert GW, et al. Central nervous system embryonal tumors with EWSR1-PLAGL1 rearrangements reclassified as INI-1 deficient tumors at relapse. J Neurooncol. 2024. PMID: 38639853. doi:10.1007/s11060-024-04667-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。